NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Phase II Study of JNJ-42756493 (Erdatfitinib) in Patients with Tumors Harboring FGFR Alterations
|Effective start/end date||10/1/19 → 9/9/21|
- Children's Hospital of Philadelphia
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.